Despite its documented ability to support hepatic steatosis, ATF4 ablation enhanced DEN-induced tumorigenesis and NASH to HCC progression in HFD-fed MUP-uPA mice. The gene discussed is ATF4; the disease is metabolic dysfunction-associated steatohepatitis.